Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Unknown 2Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 3Colorectal Neoplasms 3Lung Neoplasms 2Colonic Neoplasms 2Venous Thrombosis 1Pancreatic Ductal Adenocarcinoma 1Malignant Neoplasm of Transverse Colon 1Locally Advanced Gastric Cancer 1Endometrial Neoplasms 1Colorectal Liver Metastasis 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 34Leucovorin 31Oxaliplatin 25Irinotecan 19Capecitabine 13Folfox protocol 12Cetuximab 12Chemotherapy, Adjuvant 11Bevacizumab 9Neoadjuvant Therapy 8Drug Therapy 8XELOX 7Laparoscopy 7Endoscopic Mucosal Resection 5Colonoscopy 5Surgical Procedures, Operative 4Gemcitabine 4Tegafur 3Radiotherapy 3Propofol 3Preoperative Exercise 3Panitumumab 3Fentanyl 3Curcumin 3Colectomy 3Aspirin 3raltitrexed 2Surveys and Questionnaires 2Sodium Chloride 2Simvastatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Colonic Neoplasms × Conversion to Open Surgery × Clear all
NCT03033719 2018-01-12

CELL

Assistance Publique - Hôpitaux de Paris

Phase NA Unknown
276 enrolled
Gastrointestinal

Colonic Neoplasms

NCT02682589 2016-07-06

OLCMECC

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Unknown
1,080 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡